Lexaria Bioscience (LEXX) Institutional Ownership $2.23 +0.02 (+0.90%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Lexaria Bioscience (NASDAQ:LEXX)CurrentInstitutional OwnershipPercentage13.06%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$3.47MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$1.09M Get LEXX Insider Trade Alerts Want to know when executives and insiders are buying or selling Lexaria Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LEXX Institutional Buying and Selling by Quarter Ad WealthPress70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << Lexaria Bioscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC150,391$459K0.0%+31.0%0.951% 11/15/2024 XTX Topco Ltd18,626$57K0.0%+47.8%0.118% 11/15/2024 Invenomic Capital Management LP475,773$1.45M0.1%-7.4%3.007% 11/15/2024 HighTower Advisors LLC13,023$40K0.0%N/A0.082% 8/15/2024 Armistice Capital LLC1,020,000$2.84M0.0%N/A7.916% 8/9/2024 Renaissance Technologies LLC22,800$63K0.0%N/A0.177% 5/16/2024 Invenomic Capital Management LP473,265$1.72M0.1%-35.3%3.672% 4/9/2024 Welch Group LLC24,000$87K0.0%N/A0.194% 2/14/2024 Invenomic Capital Management LP731,981$915K0.0%-4.2%7.011% 2/8/2024 Cowen AND Company LLC256,327$320K0.1%N/A2.455% 11/15/2023 Armistice Capital LLC889,272$889K0.0%N/A10.992% 8/14/2023 Invenomic Capital Management LP766,573$560K0.0%+62.0%9.476% 8/8/2022Merit Financial Group LLC21,267$63K0.0%N/A0.357% 2/11/2022 Invenomic Capital Management LP359,113$1.45M0.3%+1.9%6.034% 11/15/2021MD Financial Management Inc.407,687$2.55M0.1%+15,078.2%7.988% 8/16/2021 Invenomic Capital Management LP317,110$2.22M0.5%+7.1%6.213% 8/13/2021 Renaissance Technologies LLC17,200$120K0.0%N/A0.337% 8/13/2021 Geode Capital Management LLC50,385$352K0.0%N/A0.987% 8/13/2021 Vanguard Group Inc.25,976$182K0.0%N/A0.509% 5/21/2021 Citadel Advisors LLC14,915$84K0.0%N/A0.292% 5/18/2021 Citadel Advisors LLC14,915$84K0.0%N/A0.292% (Data available from 1/1/2016 forward) LEXX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LEXX shares? During the previous two years, the following institutional investors and hedge funds held shares of Lexaria Bioscience shares: Armistice Capital LLC ($2.84M), Invenomic Capital Management LP ($1.45M), Geode Capital Management LLC ($459K), Cowen AND Company LLC ($320K), Welch Group LLC ($87K), Renaissance Technologies LLC ($63K), and XTX Topco Ltd ($57K).Learn more on LEXX's institutional investors. What percentage of Lexaria Bioscience stock is owned by institutional investors? 13.06% of Lexaria Bioscience stock is owned by institutional investors. Learn more on LEXX's institutional investor holdings. Which institutional investors have been buying Lexaria Bioscience stock? The following institutional investors have purchased Lexaria Bioscience stock in the last 24 months: Armistice Capital LLC ($1.91M), Invenomic Capital Management LP ($293.47K), Cowen AND Company LLC ($256.33K), Geode Capital Management LLC ($35.61K), Welch Group LLC ($24K), Renaissance Technologies LLC ($22.80K), and HighTower Advisors LLC ($13.02K). How much institutional buying is happening at Lexaria Bioscience? Institutional investors have bought a total of 2,560,524 shares in the last 24 months. This purchase volume represents approximately $4.58M in transactions. Which Lexaria Bioscience major shareholders have been selling company stock? The following institutional investors have sold Lexaria Bioscience stock in the last 24 months: Invenomic Capital Management LP ($328.87K). How much institutional selling is happening at Lexaria Bioscience? Institutional investors have sold a total of 328,867 shares in the last 24 months. This volume of shares sold represents approximately $1.09M in transactions. Related Companies ADAP Institutional Ownership PBYI Institutional Ownership TIL Institutional Ownership BDTX Institutional Ownership GALT Institutional Ownership ELUT Institutional Ownership CGEN Institutional Ownership TELO Institutional Ownership ENTA Institutional Ownership ATOS Institutional Ownership This page (NASDAQ:LEXX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexaria Bioscience Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexaria Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
